Dear [X], We are pleased to invite you to a presentation on Optimal Treatment of Hidradenitis Suppurativa at the upcoming 2023 Integrative Dermatology Symposium (IDS) Conference, taking place in Reno, Nevada. This symposium explores best practices in the management of hidradenitis suppurativa (HS), focusing on high-priority educational topics that we identified in a multistakeholder advisory board meeting conducted by Novartis Dermatology Medical Affairs in November 2022. The symposium consists of 4 consecutive, short presentations on the following topics:   • General clinical strategies and guidance regarding biologic use in HS • Unmet needs in HS treatment and the “window of opportunity” concept • Understanding the heterogeneity of HS severity and the challenge of defining “moderate” HS • The role of the HS Foundation in overcoming challenges and barriers faced by HS patients We hope to see you there! Novartis Pharmaceuticals Corporation (NPC) may not be able to offer you food or beverages if you are licensed by a state with a meal limit or prohibition, if you are a government employee or member of a formulary committee, or if your institution or affiliation prohibits your acceptance of a meal from a laws and policies. Novartis acts in accordance with the PhRMA Code on Interactions with Heath Care Professionals. The PhRMA Code states that inclusion of a health care professional’s spouse or guest at an educational program is not appropriate. Your support of these ethical guidelines will help to provide a high-quality learning environment for all participating health care professionals. Thank you. Follow Novartis US Medical Affairs 10/23  310411 To stop receiving future emails from Lake Group Media, please click here. Lake Group Media | 14241 Firestone Blvd Suite 400, La Mirada CA 90638